{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:30:19Z","timestamp":1770989419448,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a systemic inflammatory disorder associated with a significantly increased risk of cardiovascular events. This study aims to assess the prevalence of coronary artery disease (CAD) and its associated risk factors among Palestinian patients with RA, a population for which this data has been lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted from March to September 2024 at multiple rheumatology clinics in the West Bank, Palestine. The study included 384 patients with a confirmed RA diagnosis based on the American College of Rheumatology (ACR)\/European League Against Rheumatism (EULAR) criteria. Data were collected on demographic characteristics, traditional cardiovascular risk factors, and RA-specific factors, including disease activity measured by the Disease Activity Score 28 (DAS28) and C-reactive protein (CRP) levels. Multivariable analysis was used to identify independent predictors of CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of CAD in this cohort was 25.5%. Multivariable analysis revealed that CAD was independently predicted by increasing age, dyslipidemia, and a first-degree family history of CAD. Markers of systemic inflammation, specifically higher disease activity (DAS28 Prevalence Ratio\u2009=\u20091.309) and elevated CRP levels (PR up to 2.108 for levels\u2009&gt;\u200910\u00a0mg\/L), also emerged as potent and independent predictors. Furthermore, a paradoxical, non-linear association was observed with anti-CCP antibody status, where low-positive titers conferred the highest risk (PR\u2009=\u20091.811), and a modest inverse association with BMI was noted (PR\u2009=\u20090.992), consistent with the \u2018obesity paradox\u2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reveals a high prevalence of CAD among Palestinian patients with RA, driven by both traditional metabolic risk factors and RA-related systemic inflammation. The findings highlight an urgent need to integrate proactive cardiovascular disease prevention into the standard of care for RA in Palestine, recognizing RA as a cardiovascular risk-equivalent condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00613-3","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:24:55Z","timestamp":1768915495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence of coronary artery disease in rheumatoid arthritis patients in Palestine: a cross-sectional study"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8070-7767","authenticated-orcid":false,"given":"Rami","family":"Shrouf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3698-0069","authenticated-orcid":false,"given":"Aleen","family":"Aldabbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9882-3677","authenticated-orcid":false,"given":"Razan","family":"Sobeih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0642-525X","authenticated-orcid":false,"given":"Talal","family":"Asafrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7225-3575","authenticated-orcid":false,"given":"Sameh","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7693-2860","authenticated-orcid":false,"given":"Dunia","family":"Salhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Ewidat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuha","family":"Riyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alzer\u2019e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Khdour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9786-8529","authenticated-orcid":false,"given":"Ahmad","family":"Fasfoos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saed","family":"Atawnah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"613_CR1","doi-asserted-by":"publisher","unstructured":"Conforti A, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. Feb. 2021;20(2). https:\/\/doi.org\/10.1016\/j.autrev.2020.102735.","DOI":"10.1016\/j.autrev.2020.102735"},{"key":"613_CR2","doi-asserted-by":"publisher","unstructured":"Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol. May 1998;27. https:\/\/doi.org\/10.1016\/S0720-048X(98)00038-2.","DOI":"10.1016\/S0720-048X(98)00038-2"},{"key":"613_CR3","doi-asserted-by":"publisher","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. May 2021;41(5):863\u201377. https:\/\/doi.org\/10.1007\/S00296-020-04731-0.","DOI":"10.1007\/S00296-020-04731-0"},{"key":"613_CR4","doi-asserted-by":"publisher","unstructured":"Shahjehan RD, Sharma S, Bhutta BS. Coronary artery disease, mistake-based learn cardiol avoid med errors. Oct 2024;94\u2013119 https:\/\/doi.org\/10.1016\/B978-0-323-93157-1.00006-X","DOI":"10.1016\/B978-0-323-93157-1.00006-X"},{"key":"613_CR5","doi-asserted-by":"publisher","unstructured":"Lyu Q, Ma L, Liu H, Wang J. Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis, medicine (Baltimore). Nov 2023;102(45):E35912. https:\/\/doi.org\/10.1097\/MD.0000000000035912","DOI":"10.1097\/MD.0000000000035912"},{"key":"613_CR6","doi-asserted-by":"publisher","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies, Ann Rheum Dis. 2012;71(9):1524\u20131529. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"613_CR7","doi-asserted-by":"publisher","unstructured":"Chung CP et al. Oct., Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52(10):3045\u20133053. https:\/\/doi.org\/10.1002\/ART.21288","DOI":"10.1002\/ART.21288"},{"key":"613_CR8","doi-asserted-by":"publisher","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361. https:\/\/doi.org\/10.1136\/BMJ.K1036.","DOI":"10.1136\/BMJ.K1036"},{"key":"613_CR9","doi-asserted-by":"publisher","unstructured":"Ha SJ, Park SJ, Lee B, Moon H, Kim BY. Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: a Korean nationwide cohort study. PLoS One. Feb. 2023;18(2). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0281067.","DOI":"10.1371\/JOURNAL.PONE.0281067"},{"key":"613_CR10","doi-asserted-by":"publisher","unstructured":"Wang Z, et al. Factors associated with secondary coronary artery disease in rheumatoid arthritis patients: a systematic review and meta-analysis based on observational studies. Musculoskelet Care. Mar. 2023;22(1). https:\/\/doi.org\/10.1002\/MSC.1850.","DOI":"10.1002\/MSC.1850"},{"key":"613_CR11","doi-asserted-by":"publisher","unstructured":"Sugiyama D et al. Jan., Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies, Ann Rheum Dis. 2010;69(1):70\u201381. https:\/\/doi.org\/10.1136\/ard.2008.096487","DOI":"10.1136\/ard.2008.096487"},{"key":"613_CR12","doi-asserted-by":"publisher","unstructured":"Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J. May 2005;149(5):832\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2004.08.030.","DOI":"10.1016\/j.ahj.2004.08.030"},{"key":"613_CR13","doi-asserted-by":"publisher","unstructured":"Rojas-Serrano J et al. Dec., Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. a cohort study, Clin. Rheumatol. 2011;30(12):1589\u20131593. https:\/\/doi.org\/10.1007\/S10067-011-1775-5","DOI":"10.1007\/S10067-011-1775-5"},{"issue":"4","key":"613_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/AR2751","volume":"11","author":"Z Baka","year":"2009","unstructured":"Baka Z, Buz\u00e1s E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther. 2009;11(4):238. https:\/\/doi.org\/10.1186\/AR2751.","journal-title":"Arthritis Res Ther"},{"key":"613_CR15","doi-asserted-by":"publisher","unstructured":"Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet. 2011;88(4):450\u2013457. https:\/\/doi.org\/10.1016\/j.ajhg.2011.03.003","DOI":"10.1016\/j.ajhg.2011.03.003"},{"key":"613_CR16","doi-asserted-by":"publisher","unstructured":"Myasoedova E et al. Mar., Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70(3):482\u2013487. https:\/\/doi.org\/10.1136\/ard.2010.135871","DOI":"10.1136\/ard.2010.135871"},{"key":"613_CR17","doi-asserted-by":"publisher","unstructured":"Navarro-Mill\u00e1n I, et al. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the national veterans health administration. Ann Rheum Dis. Feb. 2016;75(2):341\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204987.","DOI":"10.1136\/annrheumdis-2013-204987"},{"key":"613_CR18","doi-asserted-by":"publisher","unstructured":"Zegkos T, Kitas G, Dimitroulas T. Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis. Jun. 2016;8(3):86. https:\/\/doi.org\/10.1177\/1759720X16643340.","DOI":"10.1177\/1759720X16643340"},{"key":"613_CR19","doi-asserted-by":"publisher","unstructured":"Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res. (Hoboken). Oct 2012;64(10):1471\u20131479. https:\/\/doi.org\/10.1002\/ACR.21627","DOI":"10.1002\/ACR.21627"},{"key":"613_CR20","doi-asserted-by":"publisher","unstructured":"Rezu\u0219 E, Macovei LA, Burlui AM, Cardoneanu A, Rezu\u0219 C. Ischemic heart disease and rheumatoid arthritis-two conditions, the same background. Life (Basel Switzerland). Oct. 2021;11(10). https:\/\/doi.org\/10.3390\/LIFE11101042.","DOI":"10.3390\/LIFE11101042"},{"key":"613_CR21","doi-asserted-by":"publisher","unstructured":"Zhang L, et al. Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact Mater. Dec. 2022;18:1\u201314. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.017.","DOI":"10.1016\/j.bioactmat.2022.02.017"},{"key":"613_CR22","doi-asserted-by":"publisher","unstructured":"Micha R, et al. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. Nov. 2011;108(9):1362\u201370. https:\/\/doi.org\/10.1016\/j.amjcard.2011.06.054.","DOI":"10.1016\/j.amjcard.2011.06.054"},{"key":"613_CR23","doi-asserted-by":"publisher","unstructured":"Conforti A, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. Feb. 2020;20(2). https:\/\/doi.org\/10.1016\/J.AUTREV.2020.102735.","DOI":"10.1016\/J.AUTREV.2020.102735"},{"key":"613_CR24","doi-asserted-by":"publisher","unstructured":"Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. Oct. 2007;21(5):907\u201327. https:\/\/doi.org\/10.1016\/j.berh.2007.05.007.","DOI":"10.1016\/j.berh.2007.05.007"},{"key":"613_CR25","doi-asserted-by":"publisher","unstructured":"Fihn SD, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart diseass. Circulation. Dec. 2012;126. https:\/\/doi.org\/10.1161\/CIR.0B013E318277. D6A0;WGROUP:STRING:PUBLICATION.","DOI":"10.1161\/CIR.0B013E318277"},{"key":"613_CR26","unstructured":"Park Y-B, Lee MDS-K. and M.D., Accelerated atherosclerosis in rheumatoid arthritis, J Korean Rheum Assoc Dec. 2003;10(4):335\u2013343. Accessed: Nov. 13, 2025. [Online]. Available: https:\/\/www.jrd.or.kr\/journal\/view.html?spage=335%26volume=10%26number=4"},{"key":"613_CR27","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.2147\/JMDH.S459555","volume":"17","author":"LS Alghalawin","year":"2024","unstructured":"Alghalawin LS, et al. Incidence rate of cardiovascular events in rheumatoid arthritis: an observational cohort study in Saudi Arabia. J Multidiscip Healthc. 2024;17:3357\u201370. https:\/\/doi.org\/10.2147\/JMDH.S459555.","journal-title":"J Multidiscip Healthc"},{"key":"613_CR28","doi-asserted-by":"publisher","first-page":"86116","DOI":"10.1136\/bmjopen-2024-086116","volume":"14","author":"J Al-Saleh","year":"2024","unstructured":"Al-Saleh J, et al. Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study. BMJ Open. 2024;14:86116. https:\/\/doi.org\/10.1136\/bmjopen-2024-086116.","journal-title":"BMJ Open"},{"key":"613_CR29","doi-asserted-by":"publisher","unstructured":"Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-D\u00edaz C, Anaya J-M, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America. Arthritis. Oct 2012;2012:1\u201317. https:\/\/doi.org\/10.1155\/2012\/371909","DOI":"10.1155\/2012\/371909"},{"key":"613_CR30","doi-asserted-by":"publisher","unstructured":"Kerola AM, Rollefstad S, Semb AG. Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment. Eur Cardiol Rev. 2021;16. https:\/\/doi.org\/10.15420\/ECR.2020.44.","DOI":"10.15420\/ECR.2020.44"},{"key":"613_CR31","doi-asserted-by":"publisher","unstructured":"Arts EEA, Fransen J, Den Broeder AA, Van Riel PLCM, Popa CD. Low disease activity (DAS28\u2009\u2264\u20093.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: A time-dependent Cox regression analysis in a large cohort study. Ann Rheum Dis. Oct. 2017;76(10):1693\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210997.","DOI":"10.1136\/annrheumdis-2016-210997"},{"key":"613_CR32","doi-asserted-by":"publisher","unstructured":"Iwasaki T, et al. Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency. Arthritis Res Ther. Dec. 2020;22(1). https:\/\/doi.org\/10.1186\/S13075-020-02351-4.","DOI":"10.1186\/S13075-020-02351-4"},{"key":"613_CR33","unstructured":"Iorga B, Berghea F. Obesity and cardiovascular risk in rheumatology: mechanisms and clinical implications. Rom J Rheumatol. 2024;33(3):100\u20134."},{"key":"613_CR34","doi-asserted-by":"publisher","unstructured":"Baker JF et al. Jul., Weight Loss, the Obesity paradox, and the risk of death in rheumatoid arthritis, Arthritis Rheumatol. (Hoboken, N.J.), 2015;67(7):1711. https:\/\/doi.org\/10.1002\/ART.39136","DOI":"10.1002\/ART.39136"},{"key":"613_CR35","unstructured":"Sa F, Heisler A, Mr B, Martin B, and, Ra O. Association of elevated anti-cyclic citrullinated peptide antibody titer with increased cardiovascular risk. Accessed: Nov 13, 2025. [Online]. Available: www.scholarena.com."}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00613-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00613-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00613-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:23:47Z","timestamp":1770985427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00613-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00613-3","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in strict accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Research Ethics Committee (Institutional Review Board) at Hebron University. Written informed consent was obtained from all participants after a full explanation of the study\u2019s purpose and an assurance of confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}